摩根摩根菌对碳青霉烯类药物耐药机制的研究

摘要/Abstract

摘要： 目的分析从外科重症监护病房(SICU)分离的对碳青霉烯类药物耐药的3株摩根摩根菌（M1、M2和M3）的耐药机制和传播方式。方法采用琼脂稀释法进行药物敏感性试验；肠杆菌科基因间重复性一致序列(ERIC)-聚合酶链反应（PCR）用于分析菌株的分子流行病学特征；特异性PCR 扩增检测细菌编码β-内酰胺酶的基因；接合试验和提取质粒进行酶切分析耐药基因可传递性和耐药质粒的同源性；耐药基因两边序列测序分析耐药基因的遗传背景；提取外膜蛋白电泳分析菌株外膜蛋白的改变。结果 3株分离菌和对应的接合子均扩增出介导碳青霉烯类耐药的肺炎克雷伯菌碳青霉烯酶（KPC）-2型基因，其中M1和M2为相同克隆株；质粒接合试验成功传递了对碳青霉烯类药物的耐药性，KPC-2基因被携带在酶切后片段完全不同的3个质粒上，耐药基因的遗传背景却相同；3株菌均缺失了相对分子质量约为38 000的外膜蛋白而出现36 000的外膜蛋白。结论 3株菌来自2种克隆株，均携带KPC-2基因。该基因由3个不同的质粒携带，同一可移动序列可能介导了KPC-2基因在3株细菌的不同质粒上转移。产KPC-2型碳青霉烯酶及外膜蛋白缺失可能共同导致了所分离的摩根摩根菌对碳青霉烯类抗菌药物耐药。

关键词: 摩根摩根菌, 碳青霉烯类, β-内酰胺酶, 耐药性

Abstract: Objective To investigate resistance mechanisms to carbapenems and transmission modes of 3 Morganella morganii isolates (M1， M2 and M3) isolated from patients in surgical intensive care unit (SICU). Methods The susceptibility of antimicrobial agents was detected by agar dilution method. The molecular epidemiological characteristics of the isolates were analyzed by enterobacterial repetitive intergenic consensus (ERIC)-polymerase chain reaction (PCR). The encoding genes of beta-lactamases were analyzed by specific PCR amplification. The transitivity and homology of plasmids were detected by plasmid conjugation and restriction endonuclease analysis. Genetic environments around bla_KPC were analyzed by sequencing. The changes of outer membrane permeability were analyzed by the electrophoresis of outer membrane protein. Results The bla_KPC-2 was detected by PCR in all 3 isolates and their transconjugants. M1 and M2 were the same clonal type. Carbapenem-resistance was successfully transfered by conjugation experiments. The bla_KPC-2 was located on dissimilar plasmids with quite different restriction profiles. The genetic environments around bla_KPC-2 were the same. The 3 original Morganella morganii isolates showed a loss of 38 000 outer membrane proteins, and additional 36 000 outer membrane proteins appeared compared with the Morganella morganii isolates susceptible to carbapenems. Conclusions The bla_KPC-2is detected in the 3 Morganella morganii isolates belonging to 2 clonal types . This gene encoded by dissimilar plasmids is likely located on the same mobile genetic elements by which bla_KPC-2 is possibly transferred between different plasmids. The KPC-2-producing and lack of outer membrane proteins together cause these 3 Morganella morganii isolates resistant to carbapenems possibly.

Key words: Morganella morganii, Carbapenem, Beta-lactamase, Drug resistance

施德仕;蒯守刚;邵海枫;王卫萍;张晓文. 摩根摩根菌对碳青霉烯类药物耐药机制的研究[J]. 检验医学, 2012, 27(4): 266-270.

参考文献

［1］ Queenan AM，Bush K. Carbapenemases: the versatile beta-lactamases［J］. Clin Microbiol Rev， 2007， 20(3):440-458.

［2］ Miriagou V，Cornaglia G，Edelstein M， et al. Acquired carbapenemases in Gram-negative bacterial patho-gens: detection and surveillance issues［J］. Clin Microbiol Infect， 2010， 16(2):112-122.

［3］ Nordmann P，Cuzon G，Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria［J］. Lancet Infect Dis， 2009， 9(4):228-236.

［4］ Wei G，Pan L，Du H， et al. ERIC-PCR fingerprinting-based community DNA hybridization to pinpoint genome-specific fragments as molecular markers to identify and track populations common to healthy human guts［J］. J Microbiol Methods， 2004， 59(1):91-108.

［5］ Smith Moland E，Hanson ND，Herrera VL， et al. Plasmid-mediated， carbapenem-hydrolysing beta-lactamase， KPC-2， in Klebsiella pneumoniae isolates［J］. J Antimicrob Chemother， 2003， 51(3):711-714.

［6］ Senda K，Arakawa Y，Ichiyama S， et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams［J］. J Clin Microbiol， 1996， 34(12):2909-2913.

［7］ Tsakris A，Pournaras S，Woodford N， et al. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece［J］. J Clin Microbiol， 2000， 38(3):1290-1292.

［8］ Queenan AM， Torres-Viera C， Gold HS， et al. SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains［J］. Antimicrob Agents Chemother，2000，44(11):3035-3039.

［9］ Poirel L， Heritier C， Tolun V， et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae［J］. Antimicrob Agents Chemother，2004，48(1):15-22.

［10］ Woodford N， Tierno PM， Young K， et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem hydrolyzing class A beta-lactamase，KPC-3，in a New York Medical Center［J］. Antimicrob Agents Chemother，2004，48(12):4793-4799.

［11］ Poirel L，Le Thomas I，Naas T，et al. Biochemical sequence analyses of GES-1， a novel class A extended-spectrum beta-lactamase，and the class 1 integron In52 from Klebsiella pneumoniae ［J］. Antimicrob Agents Chemother，2000，44(3):622-632.

［12］ Rasheed JK，Jay C，Metchock B， et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia［J］. Antimicrob Agents Chemother，1997，41(3):647-653.

［13］〖JP4〗Nuesch-Inderbinen MT，Hachler H，Kayser FH. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method， and comparison with the E test［J］. Eur J Clin Microbiol Infect Dis， 1996， 15(5):398-402.

［14］ Yu Y，Ji S，Chen Y，et al.Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China［J］. J Infect， 2007， 54(1):53-57.

［15］ Hernandez-Alles S，Alberti S，Alvarez D， et al. Porin expression in clinical isolates of Klebsiella pneumoniae ［J］. Microbiology，1999，145 (Pt 3):673-679.

［16］〖JP4〗Shen P，Wei Z，Jiang Y， et al. Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China［J］. Antimicrob Agents Chemother，2009，53(10):4333-4338.

［17］ Del Mar Tavio M，Vila J，Ruiz J， et al. Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii ［J］. Int J Antimicrob Agents， 2000， 14(2):157-160.

［18］ Naas T，Cuzon G，Villegas MV， et al. Genetic structures at the origin of acquisition of the beta-lactamase blaKPC gene［J］. Antimicrob Agents Chemother， 2008， 52(4):1257-1263.

［19］ Munoz-Price LS，Quinn JP. The spread of Klebsiella pneumoniae carbapenemases: a tale of strains， plasmids， and transposons［J］. Clin Infect Dis， 2009， 49(11):1739-1741.

［20］〖JP4〗Mitsuyama J，Hiruma R，Yamaguchi A，et al.Identification of porins in outer membrane of Proteus，Morganella， and Providencia spp. and their role in outer membrane permeation of beta-lactams［J］. Antimicrob Agents Chemother，1987，31(3):379-384.

[1]	李丽, 杜金烨, 王心怡, 戴菁. 肺炎克雷伯菌血流感染危险因素和菌株耐药性及毒力分析[J]. 检验医学, 2025, 40(9): 885-891.
[2]	李媛睿, 刘婧娴, 俞静, 陈峰, 刘瑛, 沈立松. 上海某三级甲等医院儿科ST11和非ST11型碳青霉烯类耐药肺炎克雷伯菌临床分布特征[J]. 检验医学, 2025, 40(9): 907-913.
[3]	鲍容, 沈佳瑾, 姚雨濛, 缪青, 王蓓丽, 潘柏申, 郭玮, 胡必杰. 上海市某三级甲等医院快生长分枝杆菌临床分离株菌种分布和耐药性[J]. 检验医学, 2025, 40(6): 540-544.
[4]	孙刚, 孙辉, 包丽娜, 刘先伟, 路明洋, 刘静, 田媛. 内蒙古呼伦贝尔地区苯唑西林敏感MRSA耐药性和分子流行病学分析[J]. 检验医学, 2025, 40(6): 551-554.
[5]	李虎, 朱威南, 陈峰, 王佳玮, 刘瑛, 沈立松, 郑英霞. 高黏液性耐碳青霉烯类肺炎克雷伯菌分子特征和毒力分析[J]. 检验医学, 2025, 40(4): 358-364.
[6]	王小龙, 王梓璇, 高丹, 杨小蓉. 新发人感染猪链球菌2例报道[J]. 检验医学, 2025, 40(12): 1237-1240.
[7]	张净, 王蒋丽, 李彩云, 刁丹红, 史婷婷, 郭莹, 李雁飞. 承德市人源性和食源性沙门菌耐药特征[J]. 检验医学, 2025, 40(11): 1109-1111.
[8]	崔兰英, 郭大文, 俞晓晨, 王希. 2019—2023年黑龙江地区临床分离真菌分布特征和耐药性分析[J]. 检验医学, 2025, 40(10): 1014-1018.
[9]	王雅文, 张盈莹, 牛文彦. 糖化血红蛋白对2型糖尿病患者尿路感染病原菌的影响[J]. 检验医学, 2024, 39(9): 895-899.
[10]	吴昕哲, 茆海丰, 杨晋, 左春磊, 金丹婷. MALDI-TOF MS直接靶板微滴生长测定法在CRKP快速检测中的应用[J]. 检验医学, 2024, 39(6): 587-591.
[11]	赵亚楠, 肖伟利, 曹啟新, 闫彦, 崔秀格, 赵建平. 围生期孕妇B族链球菌耐药性和血清型、基因型与妊娠结局的关系[J]. 检验医学, 2024, 39(4): 382-386.
[12]	陈宇, 赵雅, 王林. 慢性泪囊炎微生物分布及其耐药性[J]. 检验医学, 2024, 39(3): 256-259.
[13]	陈寰, 董方, 吕志勇, 甄景慧, 陈梅, 苏建荣. 儿童侵袭性无乳链球菌血清型和耐药性分析[J]. 检验医学, 2024, 39(3): 260-264.
[14]	马晨, 张祎, 李芳, 王静, 陈葳. 儿童侵袭性肺炎链球菌病伴坏死性肺炎临床特点、耐药性和预后不良相关因素分析[J]. 检验医学, 2024, 39(3): 265-271.
[15]	吴泉明, 陈发林, 陈丽清, 陈东杰, 黄建刚, 陈喜军, 何鑫. 铜绿假单胞菌碳青霉烯类抗菌药物单纯耐药机制分析[J]. 检验医学, 2024, 39(12): 1234-1236.